Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock

详细信息    查看全文

• 作者：Makiko Sugiura ; Chieko Mitaka ; Go Haraguchi ; Makoto Tomita…
• 关键词：Severe sepsis ; Septic shock ; Polymyxin B ; Endotoxin ; Hemodynamics ; Hemoperfusion ; Inotropic score
• 刊名：Journal of Intensive Care
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：3
• 期：1
• 全文大小：388KB
• 参考文献：1.Novelli G, Ferretti G, Poli L, Pretagostini R, Ruberto F, Perrella SM, et al. Clinical results of treatment of postsurgical endotoxin-mediated sepsis with polymyxin-B direct hemoperusion. Transplant Proc. 2010;42:1021鈥?.CrossRef PubMed
  2.Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (toraymyxin). Ther Apher Dial. 2003;7:108鈥?4.CrossRef PubMed
  3.Davies B, Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect Dis. 2011;11:65鈥?1.CrossRef PubMed
  4.Kohro S, Imaizumi H, Yamakage M, Masuda Y, Namiki A, Asai Y, et al. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth. 2006;20:11鈥?.CrossRef PubMed
  5.Ono S, Kimura A, Hiraki S, Takahata R, Tsujimoto H, Kinoshita M, et al. Removal of increased circulating CD4鈥?鈥塁D25鈥?鈥塅oxp3鈥?鈥塺egulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers. Surgery. 2013;153:262鈥?1.CrossRef PubMed
  6.Ueno T, Ikeda T, Ikeda K, Taniuchi H, Suda S, Yeung MY, et al. HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP. J Surg Res. 2011;177:183鈥?0.CrossRef
  7.Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, et al. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg. 2001;25:660鈥?.CrossRef PubMed
  8.Nakamura T, Kawagoe Y, Matsuda T, Shoji H, Ueda Y, Tamura N, et al. Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients. Blood Purif. 2004;22:256鈥?0.CrossRef PubMed
  9.Ikeda T, Ikeda K, Nagura M, Taniuchi H, Matsushita M, Kiuchi S, et al. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial. 2004;8:293鈥?.CrossRef PubMed
  10.Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445鈥?2.CrossRef PubMed
  11.Vincent JL, Laterre PF, Cohen J, Burchandi H, Bruining H, Lerma FA, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock. 2005;23:400鈥?.CrossRef PubMed
  12.Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580鈥?37.CrossRef PubMed
  13.Mitaka C, Tsuchida N, Kawada K, Nakajima Y, Imai T, Sasaki S. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Shock. 2009;32:478鈥?3.CrossRef PubMed
  14.Kambayashi J, Yokota M, Sakon M, Shiba E, Kawasaki T, Mori T, et al. A novel endotoxin-specific assay by turbidimetry with Limulus amoebocyte lysate containing 尾-glucan. J Biochem Biophys Methods. 1991;22:93鈥?00.CrossRef PubMed
  15.Zuppa AF, Nadkarni V, Davis L, Adamson PC, Helfaer MA, Elliott MR, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med. 2004;32:2318鈥?2.PubMed
  16.De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779鈥?9.CrossRef PubMed
  17.Wang Y, Liu Y, Ito Y, Hashiguchi T, Kitajima I, Yamakuchi M, et al. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal Biochem. 2001;294:73鈥?2.CrossRef PubMed
  18.Kase Y, Obata T, Okamoto Y, Iwai K, Saito K, Yokoyama K, et al. Removal of 2-arachidonylglyceral by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. Ther Apher Dial. 2008;12:374鈥?0.CrossRef PubMed
  19.Nakamura T, Kawagoe Y, Matsuda T, Koide H. Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis. Intensive Care Med. 2004;30:1838鈥?1.CrossRef PubMed
  20.Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol. 1990;259(4 Pt 2):H1038鈥?3.PubMed
  21.Szab贸 C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 1995;3:2鈥?2.PubMed
  22.Goodrum KJ, McCormick LL, Schneider B. Group B streptococcus-induced Nitric Oxide production in murine macrophages is CR3(CD11b/CD18) dependent. Infect Immun. 1994;62:3102鈥?.PubMed Central PubMed
  23.Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Critical Care. 2005;9:R653鈥?1.CrossRef PubMed Central PubMed
  24.Sato K, Maekawa H, Sakurada M, Orita H, Komatsu Y. Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe. Surg Today. 2011;41:754鈥?0.CrossRef PubMed
  25.Ronco C, Klein DJ. Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care. 2014;18:309.CrossRef PubMed Central PubMed
  
• 作者单位：Makiko Sugiura (1)
  Chieko Mitaka (2)
  Go Haraguchi (3)
  Makoto Tomita (4)
  Naohiko Inase (1)
  
  1. Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan
  2. Department of Critical Care Medicine, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
  3. Division of Intensive Care Unit, New Tokyo Hospital, Chiba, Japan
  4. Medical Clinical Research Center, Tokyo Medical and Dental University, Tokyo, Japan
  
• 刊物类别：Intensive / Critical Care Medicine;
• 刊物主题：Intensive / Critical Care Medicine;
• 出版者：BioMed Central
• ISSN：2052-0492

文摘

Background Polymyxin B-immobilized fiber column hemoperfusion (PMX) has been reported to be effective for patients with septic shock. It remains unclear, however, how the efficacy of PMX varies according to the characteristics and underlying conditions of the patients treated. The objective of the present study was to clarify the factors that result in clinical efficacy of PMX treatment.